György Németh
- Psychiatry and Mental health top 0.5%
- Schizophrenia research and treatment 41
- Bipolar Disorder and Treatment 20
- Biological Psychiatry top 2%
- Pharmacology top 2%
- Treatment of Major Depression 9
-
- Neurotransmitter Receptor Influence on Behavior 9
-
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes 13
- Mental Health Research Topics 6
-
- Child and Adolescent Psychosocial and Emotional Development 7
-
- Health Systems, Economic Evaluations, Quality of Life 5
György Németh
83 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 99
- Psychiatry and Mental health 1.6k
- Biological Psychiatry 212
- Pharmacology 460
- Cellular and Molecular Neuroscience 449
- Experimental and Cognitive Psychology 206
Countries citing papers authored by György Németh
This map shows the geographic impact of György Németh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by György Németh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites György Németh more than expected).
Fields of papers citing papers by György Németh
This network shows the impact of papers produced by György Németh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by György Németh. The network helps show where György Németh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside György Németh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | [Cariprazine, a new type - dopamine D₃ receptor preferring - partial agonist atypical antipsychotic for the treatment of schizophrenia and the primary negative symptoms]. | 2019 | 2 |
| 7 | 2018 | 43 | |
| 8 | 2018 | 53 | |
| 9 | 2018 | 22 | |
| 10 | 2017 | 29 | |
| 11 | 2017 | 236 | |
| 12 | 2017 | 47 | |
| 13 | 2017 | 29 | |
| 14 | [Investigation of CNTF, COMT, DDR1, DISC1, DRD2, DRD3, and DTNBP1 candidate genes in schizophrenia: Results from the Hungarian SCHIZOBANK Consortium]. | 2016 | 7 |
| 15 | 2016 | 92 | |
| 16 | 2015 | 57 | |
| 17 | 2015 | 137 | |
| 18 | 2014 | 147 | |
| 19 | 2011 | 15 | |
| 20 | 2008 | 3 |
About György Németh
György Németh is a scholar working on Psychiatry and Mental health, Experimental and Cognitive Psychology and Biological Psychiatry, having authored 86 papers that have together received 2.1k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (41 papers), Bipolar Disorder and Treatment (20 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (13 papers), Neurotransmitter Receptor Influence on Behavior (9 papers), Treatment of Major Depression (9 papers), Child and Adolescent Psychosocial and Emotional Development (7 papers), Mental Health Research Topics (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). The work is most often cited by research in Psychiatry and Mental health (1.6k citations), Biological Psychiatry (212 citations) and Pharmacology (460 citations). György Németh has collaborated with scholars based in Hungary, United States and Germany. Frequent co-authors include I. Laszlovszky, Suresh Durgam, Willie Earley, Kaifeng Lu, Adam Ruth, Ágota Barabássy, Raffaele Migliore, Anju Starace, B. Szatmári and Dayong Li. Their work appears in journals such as The Lancet, American Journal of Psychiatry and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.